GMAT Question of the Day - Daily to your Mailbox; hard ones only

 It is currently 14 Oct 2019, 16:41

### GMAT Club Daily Prep

#### Thank you for using the timer - this advanced tool can estimate your performance and suggest more practice questions. We have subscribed you to Daily Prep Questions via email.

Customized
for You

we will pick new questions that match your level based on your Timer History

Track

every week, we’ll send you an estimated GMAT score based on your performance

Practice
Pays

we will pick new questions that match your level based on your Timer History

# Drug company manager: Our newest product is just not selling. One way

Author Message
TAGS:

### Hide Tags

VP
Joined: 30 Jan 2016
Posts: 1158
Drug company manager: Our newest product is just not selling. One way  [#permalink]

### Show Tags

30 Oct 2018, 09:46
2
00:00

Difficulty:

45% (medium)

Question Stats:

63% (01:38) correct 37% (01:47) wrong based on 241 sessions

### HideShow timer Statistics

Drug company manager: Our newest product is just not selling. One way to save it would be a new marketing campaign. This would not guarantee success, but it is one chance to save the product, so we should try it.

Which one of the following, if true, most seriously weakens the manager’s argument?

(A) The drug company has invested heavily in its newest product, and losses due to this product would be harmful to the company’s profits.
(B) Many new products fail whether or not they are supported by marketing campaigns.
(C) The drug company should not undertake a new marketing campaign for its newest product if the campaign has no chance to succeed.
(D) Undertaking a new marketing campaign would endanger the drug company’s overall position by necessitating cutbacks in existing marketing campaigns.
(E) Consumer demand for the drug company’s other products has been strong in the time since the company’s newest product was introduced.

_________________
Non progredi est regredi
Board of Directors
Status: QA & VA Forum Moderator
Joined: 11 Jun 2011
Posts: 4765
Location: India
GPA: 3.5
Re: Drug company manager: Our newest product is just not selling. One way  [#permalink]

### Show Tags

30 Oct 2018, 10:50
1
Akela wrote:
Drug company manager: Our newest product is just not selling. One way to save it would be a new marketing campaign. This would not guarantee success, but it is one chance to save the product, so we should try it.

Which one of the following, if true, most seriously weakens the manager’s argument?

(A) The drug company has invested heavily in its newest product, and losses due to this product would be harmful to the company’s profits.
(B) Many new products fail whether or not they are supported by marketing campaigns.
(C) The drug company should not undertake a new marketing campaign for its newest product if the campaign has no chance to succeed.
(D) Undertaking a new marketing campaign would endanger the drug company’s overall position by necessitating cutbacks in existing marketing campaigns.
(E) Consumer demand for the drug company’s other products has been strong in the time since the company’s newest product was introduced.

Clean (D) If the proposed plan of action is doesn't guarantee expected return/results then Investment in that programme would be detrimental to the Interest of the COmpany , as such thr suggested course of action may not be adopted.
_________________
Thanks and Regards

Abhishek....

PLEASE FOLLOW THE RULES FOR POSTING IN QA AND VA FORUM AND USE SEARCH FUNCTION BEFORE POSTING NEW QUESTIONS

How to use Search Function in GMAT Club | Rules for Posting in QA forum | Writing Mathematical Formulas |Rules for Posting in VA forum | Request Expert's Reply ( VA Forum Only )
Manager
Joined: 07 Apr 2018
Posts: 101
Location: United States
Concentration: General Management, Marketing
GMAT 1: 600 Q45 V28
GPA: 3.8
Re: Drug company manager: Our newest product is just not selling. One way  [#permalink]

### Show Tags

30 Oct 2018, 13:22
what is wrong with B!
Is it the word many?
Manager
Joined: 21 May 2017
Posts: 99
Location: India
GMAT 1: 660 Q49 V31
Re: Drug company manager: Our newest product is just not selling. One way  [#permalink]

### Show Tags

30 Oct 2018, 20:01
1
HAPPYatHARVARD wrote:
what is wrong with B!
Is it the word many?

HAPPYatHARVARD: Yes , even if many new products fails , there is no guarantee that this product will also fail. So this choice does not weaken the argument.
Intern
Joined: 03 Jul 2018
Posts: 18
Re: Drug company manager: Our newest product is just not selling. One way  [#permalink]

### Show Tags

30 Oct 2018, 20:07
1
zac123 wrote:
HAPPYatHARVARD wrote:
what is wrong with B!
Is it the word many?

HAPPYatHARVARD: Yes , even if many new products fails , there is no guarantee that this product will also fail. So this choice does not weaken the argument.

Zac123 option says a generic statement which may or may not be applicable to the said product/ business / company so its not an option to even think about

Posted from my mobile device
Manager
Joined: 07 Apr 2018
Posts: 101
Location: United States
Concentration: General Management, Marketing
GMAT 1: 600 Q45 V28
GPA: 3.8
Re: Drug company manager: Our newest product is just not selling. One way  [#permalink]

### Show Tags

30 Oct 2018, 20:38
1
zac123 If the question would have said "most" rather than "many", then we could have gone for B.
Intern
Joined: 11 Jun 2017
Posts: 1
Location: India
Schools: HBS '21
GMAT 1: 680 Q48 V35
GPA: 4
Re: Drug company manager: Our newest product is just not selling. One way  [#permalink]

### Show Tags

30 Oct 2018, 21:01
Abhishek009 wrote:
Akela wrote:
Drug company manager: Our newest product is just not selling. One way to save it would be a new marketing campaign. This would not guarantee success, but it is one chance to save the product, so we should try it.

Which one of the following, if true, most seriously weakens the manager’s argument?

(A) The drug company has invested heavily in its newest product, and losses due to this product would be harmful to the company’s profits.
(B) Many new products fail whether or not they are supported by marketing campaigns.
(C) The drug company should not undertake a new marketing campaign for its newest product if the campaign has no chance to succeed.
(D) Undertaking a new marketing campaign would endanger the drug company’s overall position by necessitating cutbacks in existing marketing campaigns.
(E) Consumer demand for the drug company’s other products has been strong in the time since the company’s newest product was introduced.

Clean (D) If the proposed plan of action is doesn't guarantee expected return/results then Investment in that programme would be detrimental to the Interest of the COmpany , as such thr suggested course of action may not be adopted.

But isn't option D talking about effects on other marketing campaign. It doesn't mention anything about the new product.
Senior Manager
Joined: 09 Aug 2017
Posts: 483
Re: Drug company manager: Our newest product is just not selling. One way  [#permalink]

### Show Tags

30 Oct 2018, 21:07
How I took this CRQ is as below.

(A) The drug company has invested heavily in its newest product, and losses due to this product would be harmful to the company’s profits.
And if a market campaign has any chance of saving this product, company can try at least. Strengthener.

(B) Many new products fail whether or not they are supported by marketing campaigns.
We are worried about product mentioned in stimuli, not in many products. Irrelevant.

(C) The drug company should not undertake a new marketing campaign for its newest product if the campaign has no chance to succeed.
This is kind of assertion, not a logical weakener. Moreover, although it has no guarantee of success but chances to save the product still exist through this campaign.

(D) Undertaking a new marketing campaign would endanger the drug company’s overall position by necessitating cutbacks in existing marketing campaigns.
Market campaign will endanger company's overall position and also cuts in existing market campaign. We already no there is no guarantee of success. Overall, this campaign will negatively impact company's overall value.
Weakener.

(E) Consumer demand for the drug company’s other products has been strong in the time since the company’s newest product was introduced.
Profit from other products can be invested in market campaign of new product. Strengthener.

D is correct weakener.
Manager
Joined: 21 May 2017
Posts: 99
Location: India
GMAT 1: 660 Q49 V31
Re: Drug company manager: Our newest product is just not selling. One way  [#permalink]

### Show Tags

30 Oct 2018, 21:11
2
HAPPYatHARVARD wrote:
zac123 If the question would have said "most" rather than "many", then we could have gone for B.

No We still would not go for B because , as stated by srtas its still a very generic statement which may include anything thing other than a new drug . But we are only concerned with marketing of new drug.
Hope this helps.
Intern
Joined: 30 Jul 2018
Posts: 18
Re: Drug company manager: Our newest product is just not selling. One way  [#permalink]

### Show Tags

31 Oct 2018, 00:10
Stuck between C and D. Chose C

Sent from my iPhone using GMAT Club Forum mobile app
Manager
Joined: 21 May 2017
Posts: 99
Location: India
GMAT 1: 660 Q49 V31
Re: Drug company manager: Our newest product is just not selling. One way  [#permalink]

### Show Tags

31 Oct 2018, 00:18
1
HAPPYatHARVARD : most means more that 50% , can we conclude that the product we are talking aboult will be included in this?
It can be 51% or it can be 100% , we cannot be sure .

Posted from my mobile device
Manager
Joined: 07 Apr 2018
Posts: 101
Location: United States
Concentration: General Management, Marketing
GMAT 1: 600 Q45 V28
GPA: 3.8
Re: Drug company manager: Our newest product is just not selling. One way  [#permalink]

### Show Tags

31 Oct 2018, 00:26
1
zac123 right.
These are the rules for CR
-Try to avoid extreme answers in CR. (Must,should, only etc...)
-Most of them, Some people , Many etc..Be cautious because we don't what percentage of the people or group are some, many or most referred to.
Manager
Joined: 31 May 2015
Posts: 129
Re: Drug company manager: Our newest product is just not selling. One way  [#permalink]

### Show Tags

31 Oct 2018, 02:34
I thought in gmat we must no be aware of other factors involved, like in this case with ans. D we are concerned about the well being of the company while ans. C focuses on the new product only.
_________________
GMAT loosers are born not made !!!
Manhattan Prep Instructor
Joined: 22 Mar 2011
Posts: 1564
Re: Drug company manager: Our newest product is just not selling. One way  [#permalink]

### Show Tags

31 Oct 2018, 12:04
2
HAPPYatHARVARD Be careful with that rule about extremes. It makes sense for Inference, but not for Strengthen/Weaken. If I am trying to weaken an argument, an extreme statement can be EXTREMELY helpful. However, noticing SHOULD is important. The appearance of that word in the conclusion is the key to this question.

The author states that a particular action may be helpful, and therefore concludes that the company SHOULD take that action. This relies on an assumption that there is no reason NOT to take that action. Any answer that gives us a compelling reason not to run a new marketing campaign for the product will be a winner. We don't need to definitively prove that the campaign will be bad--we just need to weaken the idea that it will be good.

C is understandably tempting, but it is a conditional with an unfulfilled condition. In other words, it says "If no chance, then don't do it." But we don't know there's no chance, so C has zero effect on the argument.

B doesn't add to our understanding, either. We already know that the product may fail with or without the campaign, so B doesn't change anything. (As for the word "many," we can interpret it the same way as "some": basically, more than zero and that's it! There's no clear threshold for what "many" means. It's very dependent on context and interpretation.)

D introduces a clear drawback to undertaking the campaign. This is the kind of new information we were looking for! Note that it doesn't PROVE the argument wrong. Maybe the campaign would be a smashing success, but it introduces a big risk for the whole company, and that's a pretty compelling reason to go against the author's conclusion. sony1000, we have a pretty wide-open mission here, because the conclusion just said "We should do this." If the conclusion had been more narrowly focused on a specific effect (e.g. "The campaign will increase awareness of this product by 20%"), then information about the overall effect on the company would be out of scope.
_________________

Dmitry Farber | Manhattan Prep GMAT Instructor | San Diego

Manhattan GMAT Discount | Manhattan GMAT Course Reviews | View Instructor Profile |
Manhattan GMAT Reviews
Manager
Joined: 07 Apr 2018
Posts: 101
Location: United States
Concentration: General Management, Marketing
GMAT 1: 600 Q45 V28
GPA: 3.8
Re: Drug company manager: Our newest product is just not selling. One way  [#permalink]

### Show Tags

31 Oct 2018, 18:39
DmitryFarber Thanks Dmitry for correcting me. You are right, extreme answers are helpful in strengthening and weakening questions.We can negate extreme answers only in main point, inference and conclusion based questions.
Re: Drug company manager: Our newest product is just not selling. One way   [#permalink] 31 Oct 2018, 18:39
Display posts from previous: Sort by